Patent & IP news for September 15, 2014

Patent Litigations

USPTO Weekly Stats


Patent & IP Blogs

post image Broad Claims with narrow support – Vorrichtung zur Schwingungserzeugung from

The decision 4 Ni 16/11 of the 4th senate of the Bundespatentgericht (BPatG) is worthwhile noting because it approaches the jurisdiction of the BPatG with a jurisdiction of the Technical Boards of Appeal of ...

Share via E–mail | Twitter | Facebook

post image Do people know that patents exist? A judge opines from

OOO Abbott & Another v Design & Display Ltd & Another [2014] EWHC 2924 (IPEC) is a 4 September 2014 ruling of Judge Hacon in the Intellectual Property Enterprise Court, England and Wales, on the subject of calculation ...

Share via E–mail | Twitter | Facebook

USPTO AIA Roadshow from

The U.S. Patent and Trademark Office will be hosting seven roadshow events between September 16 and October 9 to increase understanding of the First Inventor to File (FITF) provisions of the Leahy-Smith America Invents ...

Share via E–mail | Twitter | Facebook

Conference & CLE Calendar from

September 16, 2014 - "Section 103 and Obviousness: Capitalizing on CCPA and Early Federal Circuit Precedent -- Strategies for Withstanding Obviousness Rejections and Attacks on Patent Validity and Patentability" (Strafford) - 1:00 to 2:30 pm (EDT ...

Share via E–mail | Twitter | Facebook

BCP Customer Partnership Meeting from

The U.S. Patent and Trademark Office will be holding its next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting on Wednesday, September 17, 2014. The latest BCP meeting will be the Office's first Bicoastal ...

Share via E–mail | Twitter | Facebook

Court Report from

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Millennium Pharmaceuticals Inc. v. Glenmark Pharmaceuticals Ltd. et al. 1:14-cv-01156; filed September 10, 2014 in ...

Share via E–mail | Twitter | Facebook

WIPO Committee Advances Decisions On Programme, Budget, Oversight from

The powerful World Intellectual Property Organization Program and Budget Committee in its recent meeting worked through a tough agenda of core decisions about the UN organisation’s functioning and future. The committee reached decisions on ...

Share via E–mail | Twitter | Facebook

IPR Petitioner’s Business Model to Circumvent 35 U.S.C. § 315(b) Time Bar No Basis for Terminating Sanctions from

During a conference call, the Board denied the patent owner's request to file a motion for sanctions terminating the proceedings. "Patent Owner argues that [a motion for sanctions pursuant to 37 C.F.R ...

Share via E–mail | Twitter | Facebook

PTO petition republication request from

C.F.R. § 1.221 allows an Applicant to correct errors in published applications by filing a petition which identifies the errors and requests republication. This week I'll review a small sample of Petition ...

Share via E–mail | Twitter | Facebook

Finding the limits of ineligibility from

by Dennis Crouch It is safe to say that hundreds of thousands of U.S. patents rely upon the manipulation of information or laws of nature as fundamental aspects of their respective inventions. Many of ...

Share via E–mail | Twitter | Facebook

African Declaration On Internet Rights And Freedoms from

Last week, 23 civil society groups released the African Declaration on Internet Rights and Freedoms at the Internet Governance Forum, reports. The declaration is organized around twelve key principles, including Freedom of Expression ...

Share via E–mail | Twitter | Facebook

Interval Licensing v. AOL: Post-Nautilus Indefiniteness from

By Jason Rantanen Interval Licensing LLC v. AOL, Inc. (Fed. Cir. 2014) Interval v AOL Panel: Taranto and Chen (author)* One of the most frequent criticisms of Nautilius v. Biosig is that it simply provides ...

Share via E–mail | Twitter | Facebook

Experts Look At The Meaning of Myriad, One Year Later from

IRVINE, CALIFORNIA – Experts gathered here last week addressed the question of – one year later - what does the United States Supreme Court’s decision on human gene patents mean for scientific research and patent policy?

Share via E–mail | Twitter | Facebook

Some content © 2007–2014 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact